STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 62 filers reported holding STEMLINE THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $12,390,000 | -20.1% | 1,449,073 | 0.0% | 0.01% | -25.0% |
| Q4 2016 | $15,505,000 | -12.8% | 1,449,073 | -11.8% | 0.01% | -11.1% |
| Q3 2016 | $17,785,000 | +25.0% | 1,642,197 | -21.9% | 0.01% | +12.5% |
| Q2 2016 | $14,232,000 | +62.4% | 2,102,200 | +11.8% | 0.01% | +60.0% |
| Q1 2016 | $8,761,000 | -13.7% | 1,880,030 | +16.8% | 0.01% | 0.0% |
| Q4 2015 | $10,155,000 | -26.2% | 1,609,330 | +3.3% | 0.01% | -28.6% |
| Q3 2015 | $13,762,000 | -25.0% | 1,558,530 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $18,344,000 | -4.1% | 1,558,530 | +17.9% | 0.01% | -11.1% |
| Q1 2015 | $19,125,000 | +15.4% | 1,321,730 | +36.0% | 0.01% | +12.5% |
| Q4 2014 | $16,578,000 | +36.9% | 971,730 | 0.0% | 0.01% | +33.3% |
| Q3 2014 | $12,108,000 | -29.0% | 971,730 | -16.4% | 0.01% | -25.0% |
| Q2 2014 | $17,054,000 | -27.3% | 1,162,530 | +0.9% | 0.01% | -27.3% |
| Q1 2014 | $23,462,000 | +53.3% | 1,152,348 | +47.5% | 0.01% | +57.1% |
| Q4 2013 | $15,308,000 | -19.5% | 781,000 | +86.1% | 0.01% | -30.0% |
| Q3 2013 | $19,008,000 | +202.9% | 419,700 | +59.5% | 0.01% | +150.0% |
| Q2 2013 | $6,275,000 | – | 263,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |